Immune Response Following COVID-19 in Hemodialysis Patients

Key facts

Sponsor

AURA Paris

Principal Investigator

Maxime Touzot, MD, PhD

AURA Paris

Enrollment

21 enrolled

Eligibility

18 years · All sexes

Timeline

2020 – 2021

Study locations (1)

• AURA Paris, Paris, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Complication in hemodialysis

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGNCT07438925
  Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure Variation
  Central Hospital, Nancy, France
• RECRUITINGNANCT06341452
  Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
  Fresenius Medical Care Deutschland GmbH
• RECRUITINGNANCT07512895
  The Effect of Progressive Muscle Relaxation Exercises on Depression and Fatigue in Patients Receiving Hemodialysis Treatment: A Randomized Controlled Trial
  Istanbul Aydın University
• RECRUITINGNANCT07269379
  Intradialytic Exercise With Blood Flow Restriction in Hemodialysis Patients
  University of Avignon
• ACTIVE NOT RECRUITINGNCT07412834
  Safely Disconnect From the Dialysis Machine in an Emergency Situation
  Istanbul University
• RECRUITINGPHASE1NCT07217886
  A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls
  Shionogi
• RECRUITINGNANCT06978127
  Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
  University of Pittsburgh
• ACTIVE NOT RECRUITINGPHASE3NCT06901505
  To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis
  Akebia Therapeutics

See all trials for Complication in hemodialysis →